Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 4, Pages -Publisher
MDPI
DOI: 10.3390/ijms22041792
Keywords
epidermolysis bullosa; RDEB; disease mutation; splicing; dermal fibroblast; differential gene expression; cell culture; extracellular matrix
Funding
- Russian Foundation for Basic Research [19-34-90066, 19-2904044]
- Ministry of Science and Higher Education of the Russian Federation [075-15-2019-1789]
Ask authors/readers for more resources
The recessive form of dystrophic epidermolysis bullosa, caused by impairments in the junctions of the dermis and the basement membrane, is associated with mutations in the COL7A1 gene. Specific mutations in COL7A1 were identified through analysis of RDEB fibroblast lines, showing distinct morphological features and contraction capacity compared to control fibroblasts. RNA-seq data analysis and gene expression studies revealed differential gene expression and potential mechanisms involved in disease progression.
The recessive form of dystrophic epidermolysis bullosa (RDEB) is a debilitating disease caused by impairments in the junctions of the dermis and the basement membrane of the epidermis. Mutations in the COL7A1 gene induce multiple abnormalities, including chronic inflammation and profibrotic changes in the skin. However, the correlations between the specific mutations in COL7A1 and their phenotypic output remain largely unexplored. The mutations in the COL7A1 gene, described here, were found in the DEB register. Among them, two homozygous mutations and two cases of compound heterozygous mutations were identified. We created the panel of primary patient-specific RDEB fibroblast lines (FEB) and compared it with control fibroblasts from healthy donors (FHC). The set of morphological features and the contraction capacity of the cells distinguished FEB from FHC. We also report the relationships between the mutations and several phenotypic traits of the FEB. Based on the analysis of the available RNA-seq data of RDEB fibroblasts, we performed an RT-qPCR gene expression analysis of our cell lines, confirming the differential status of multiple genes while uncovering the new ones. We anticipate that our panels of cell lines will be useful not only for studying RDEB signatures but also for investigating the overall mechanisms involved in disease progression.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available